Daniel E. Morse
Corporate Officer/Principal chez University of California, Santa Barbara
Profil
Daniel E.
Morse is the founder of SBA Materials, Inc. (founded in 2001).
He is currently a Professor at the University of California, Santa Barbara (since 1973).
Dr. Morse has held former positions as Director & Executive Vice President at CAG Capital, Inc. (2010), Independent Director at Stellar Biotechnologies, Inc. (2010-2018), and Vice President-Science & Technology at Stellar Biotechnologies, Inc. (2010-2011).
He obtained his undergraduate degree from Harvard University and his doctorate from Albert Einstein College of Medicine, Inc.
Postes actifs de Daniel E. Morse
| Sociétés | Poste | Début |
|---|---|---|
| University of California, Santa Barbara | Corporate Officer/Principal | 01/01/1973 |
Anciens postes connus de Daniel E. Morse
| Sociétés | Poste | Fin |
|---|---|---|
Stellar Biotechnologies, Inc.
 Stellar Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Stellar Biotechnologies, Inc. engages in the research, development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH), an immune-stimulating protein utilized as a carrier molecule in therapeutic vaccines and for assessing immune system function. Its product portfolio includes Stellar KLH Products, Stellar KLH Protein, and Stellar KLH ELISA Kits. The Company was founded in 1999 and is headquartered in Port Hueneme, CA. | Directeur/Membre du Conseil | 28/09/2018 |
| Stellar Biotechnologies, Inc. /Old/ | Directeur Technique/Scientifique/R&D | 01/12/2011 |
CAG Capital, Inc.
 CAG Capital, Inc. Financial ConglomeratesFinance CAG Capital Inc. is a capital pool company. The company's principal business is to identify and evaluate businesses and assets and, once identified and evaluated, to negotiate an acquisition subject to receipt of the approval of the TSX venture exchange. The company has not conducted commercial operations other than to enter into discussions for the purpose of identifying potential acquisitions or interest. | Directeur/Membre du Conseil | 20/04/2010 |
SBA Materials, Inc.
 SBA Materials, Inc. Electronic Production EquipmentElectronic Technology SBA Materials, Inc. develops engineered nano-structured materials. It engages in the development and commercialization of advanced electronic materials for back-end of line and packaging applications for semiconductor manufacturing. The firm has advanced electronic materials to address unmet needs of today's and tomorrow's electronic device manufacturers. The company was founded by Bradley F. Chmelka, William E. Cook, Daniel E. Morse and Galen D. Stucky in 2001 and is headquartered in San Jose, CA. | Fondateur | - |
Formation de Daniel E. Morse
| Harvard University | Undergraduate Degree |
| Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
CAG Capital, Inc.
CAG Capital, Inc. Financial ConglomeratesFinance CAG Capital Inc. is a capital pool company. The company's principal business is to identify and evaluate businesses and assets and, once identified and evaluated, to negotiate an acquisition subject to receipt of the approval of the TSX venture exchange. The company has not conducted commercial operations other than to enter into discussions for the purpose of identifying potential acquisitions or interest. | Finance |
| Stellar Biotechnologies, Inc. /Old/ | Health Technology |
SBA Materials, Inc.
SBA Materials, Inc. Electronic Production EquipmentElectronic Technology SBA Materials, Inc. develops engineered nano-structured materials. It engages in the development and commercialization of advanced electronic materials for back-end of line and packaging applications for semiconductor manufacturing. The firm has advanced electronic materials to address unmet needs of today's and tomorrow's electronic device manufacturers. The company was founded by Bradley F. Chmelka, William E. Cook, Daniel E. Morse and Galen D. Stucky in 2001 and is headquartered in San Jose, CA. | Electronic Technology |
Stellar Biotechnologies, Inc.
Stellar Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Stellar Biotechnologies, Inc. engages in the research, development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH), an immune-stimulating protein utilized as a carrier molecule in therapeutic vaccines and for assessing immune system function. Its product portfolio includes Stellar KLH Products, Stellar KLH Protein, and Stellar KLH ELISA Kits. The Company was founded in 1999 and is headquartered in Port Hueneme, CA. | Health Technology |
